The overall goals of this project are to leverage our expertise in animal models of TB and in vivo bioimaging to understand the biodistribution of new antimicrobials into diseased pulmonary tissues, specifically cavitary lesions. We will also gain mechanistic insights to optimize TB treatments and develop tools to accurately characterize and phenotype TB disease.